NUMI
Year-over-year NUMI has increased their revenue, decreased their net losses, and increased prospects in the market.
This is a high risk, high reward scenario. I'm hoping they can lobby govt to move forward with trials and clinical use!
I'm in for 10,000 shares. LFG! WGMI!